HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Canter Selected Research

Obesity

3/2024Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?
10/2023Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data.
1/2022Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the "obesity paradox".
12/2021Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects.
11/2020Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation.
1/2019Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.
1/2018Obesity as an immune-modifying factor in cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J Canter Research Topics

Disease

69Neoplasms (Cancer)
04/2024 - 08/2002
29Sarcoma (Soft Tissue Sarcoma)
03/2024 - 11/2007
10Neoplasm Metastasis (Metastasis)
03/2024 - 09/2006
7Obesity
03/2024 - 01/2018
7Breast Neoplasms (Breast Cancer)
05/2021 - 11/2010
6Melanoma (Melanoma, Malignant)
01/2022 - 01/2003
5Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 11/2012
4Synovial Sarcoma (Synovioma)
11/2020 - 12/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 10/2016
2Adenocarcinoma
01/2024 - 03/2015
2Bronchiolitis Obliterans Syndrome
12/2021 - 11/2020
2Ascites
11/2021 - 08/2011
2Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 01/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 10/2015
2Male Breast Neoplasms (Male Breast Cancer)
05/2021 - 07/2019
2Disease Progression
01/2021 - 01/2020
2Margins of Excision
11/2020 - 06/2019
2Fistula
01/2020 - 09/2009
2Ewing Sarcoma (Sarcoma, Ewing)
01/2019 - 10/2016
2Abscess
06/2016 - 09/2009
2Pain (Aches)
10/2014 - 04/2013
2Surgical Wound Infection
12/2013 - 11/2011
2Noninfiltrating Intraductal Carcinoma (DCIS)
01/2013 - 09/2012
2Lymphatic Metastasis
09/2011 - 12/2010
1Hematologic Diseases (Blood Diseases)
12/2021
1Ovarian Neoplasms (Ovarian Cancer)
11/2021
1Sepsis (Septicemia)
11/2021
1Virus Diseases (Viral Diseases)
10/2021
1Leukemia
05/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2020
1Sarcopenia
10/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Microsatellite Instability
01/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Cytokine Release Syndrome
01/2018
1Rhabdomyosarcoma
10/2016
1Empyema
06/2016
1Gallstones (Gallstone)
06/2016
1Aggressive Fibromatosis (Desmoid)
01/2016

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2019
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
4Interleukin-15 (Interleukin 15)IBA
01/2022 - 09/2015
4CytokinesIBA
12/2021 - 01/2020
4Estrogen ReceptorsIBA
05/2021 - 09/2011
3Sorafenib (BAY 43-9006)FDA Link
03/2024 - 05/2014
3Aldehyde DehydrogenaseIBA
03/2024 - 10/2015
3LigandsIBA
01/2016 - 09/2015
3Progesterone Receptors (Progesterone Receptor)IBA
09/2012 - 09/2011
3Melphalan (Alkeran)FDA LinkGeneric
09/2005 - 01/2003
2Tyrosine Kinase InhibitorsIBA
03/2024 - 10/2014
2Interleukin-2 (IL2)IBA
01/2023 - 09/2015
2Hormones (Hormone)IBA
05/2021 - 12/2010
2AlbuminsIBA
01/2018 - 11/2011
2CreatinineIBA
11/2011 - 08/2011
2Proteins (Proteins, Gene)FDA Link
09/2005 - 01/2003
1atezolizumabIBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2023
1Bacterial DNAIBA
01/2023
1Toll-Like Receptor 4IBA
01/2022
1SuspensionsIBA
01/2021
1Granzymes (Granzyme)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
11/2020
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1AntibodiesIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020
1PerforinIBA
01/2020
1Proteasome InhibitorsIBA
01/2019
1Bortezomib (Velcade)FDA Link
01/2019
1micaIBA
01/2019
1LeptinIBA
01/2019
1C-Reactive ProteinIBA
01/2018
1Natural Cytotoxicity Triggering Receptor 2IBA
01/2018
1Platelet-Derived Growth FactorIBA
01/2018
1Hemoglobins (Hemoglobin)IBA
01/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2016
1Antigen-Antibody Complex (Immune Complex)IBA
01/2016

Therapy/Procedure

27Immunotherapy
04/2024 - 09/2015
25Therapeutics
03/2024 - 08/2002
25Radiotherapy
01/2023 - 11/2010
17Drug Therapy (Chemotherapy)
03/2024 - 11/2007
7Neoadjuvant Therapy
01/2018 - 10/2010
5Length of Stay
10/2019 - 09/2009
4Mastectomy (Mammectomy)
07/2019 - 12/2010
3Hematopoietic Stem Cell Transplantation
12/2021 - 11/2020
3Segmental Mastectomy (Lumpectomy)
05/2021 - 09/2012
2Pancreatectomy
03/2022 - 10/2021
2Conservative Treatment
05/2020 - 01/2016
2Palliative Care (Palliative Therapy)
01/2020 - 04/2018
2Combined Modality Therapy
01/2019 - 07/2015
2Pancreaticoduodenectomy
01/2018 - 03/2015
1Stem Cell Transplantation
11/2020
1Chemoradiotherapy
11/2017
1Investigational Therapies (Experimental Therapy)
10/2016
1Laparoscopic Cholecystectomy
06/2016
1Cholecystectomy
06/2016
1Terminal Care (Care, Terminal)
01/2016